GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anixa Biosciences ANIX · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.60

-4.06%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Anixa Biosciences — daily ANIX Delayed
Market value
$84.4m
Last close × shares
Volume
227.2k
Shares, 19 Nov 2026

About Anixa Biosciences

From its filings with the US Securities and Exchange Commission

SEC filings

Anixa Biosciences is based in San Jose, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ANIX. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 October 2024, it reported revenue of $210,000.

In its own words

Biosciences, Inc. is a biotechnology company developing therapies and vaccines that are focused on critical unmet needs in oncology.

(Keytruda®). In June 2025, we completed enrollment in the Phase 1 trial and in October 2025, we completed all patient clinical visits.

Islander women, and ranges from 92% to 31% based on whether it is first diagnosed at a local stage or a distant stage, respectively.

Expressway, San Jose, California 95118, our telephone number is (408) 708-9808 and our Internet website address is www.anixa.com.

Quoted from its 10-K, filed 12 Jan 2026. Read the filing on SEC.gov ↗

More about Anixa Biosciences →

How it makes its money

Revenue, year to 31 Oct 2019

  • Patent Licensing [Member] $250,000 · 100.0%

Latest on Anixa Biosciences

Our reporting

Next results

11 Jan 2027

Due on 11 Jan 2027. Analysts expect earnings of -0.08 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Anixa Biosciences's ticker?

Anixa Biosciences trades as ANIX on its US listing, under ISIN US03528H1095.

What was Anixa Biosciences's last closing price?

2.60 on 19 Nov 2026. The figure is in USD and is never converted.

When does Anixa Biosciences next report results?

Results are expected on 11 Jan 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.